General Information of the Compound
Compound ID
CP0294916
Compound Name
(S)-3-(aminomethyl)-5-methylhexanoic acid
    Show/Hide
Synonyms
Pregabalin
Pregabalin (controlled-release, oral)
Pregabalin (controlled-release, oral), Pfizer
Pregabalin CR
    Show/Hide
Structure
Formula
C8H17NO2
Molecular Weight
159.229
Canonical SMILES
CC(C)C[C@H](CN)CC(O)=O
    Show/Hide
InChI
InChI=1S/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11)/t7-/m0/s1
    Show/Hide
InChIKey
AYXYPKUFHZROOJ-ZETCQYMHSA-N
CAS
148553-50-8
Physicochemical Property
logP
1.0821
Rotatable Bonds
5
Heavy Atom Count
11
Polar Areas
63.32
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
11

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5486971
SID: 12014780
ChEMBL ID
CHEMBL1059
DrugBank ID
DB00230
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Pregabalin )
Drug Name Pregabalin
Company Pfizer
Indication
Chronic obstructive pulmonary disease
Approved
Target(s)
Voltage-gated calcium channel alpha-2/delta-1 (CACNA2D1)
Modulator